Letter: Physicians defend use of antipsychotics in nursing homes

Share this article:

Geriatric psychiatrists are defending the use of antipsychotics given to nursing home residents with dementia following a series of Boston Globe articles about the over-prescribing of such medications.

In a letter to the editor, two members of the Massachusetts Psychiatric Society assert that while non-drug behavioral interventions should be used foremost in treating agitation and aggression in dementia residents, the use of off-label medications is a “medically accepted treatment approach,” according to David Harnett, M.D., and James Ellison, M.D.

The “demonization of anti-psychotics may limit treatment options and discourage nursing homes from accepting behaviorally difficult patients. These institutions deserve our support, not condemnation,” they wrote.

Hartnett and Ellison were responding to a package of Boston Globe articles that examined the amount of facilities that use antipsychotics more than is federally recommended.

Click here to read the full letter.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...